Murilo Ramos Rocha

8PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 21, 2024
Wnt/β-catenin pathway as a link between therapy resistance-driven epithelial-mesenchymal transition and stemness in colorectal cancer.

Murilo Ramos Rocha, Yuri Kelly Castillo-Medina, Bárbara Martins de Lima Coelho

|Jul 15, 2024
Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis.

Gretchen M Alicea, Payal Patel, Marie E Portuallo

|Jul 29, 2023
Açaí (Euterpe oleracea Mart.) Seed Oil Exerts a Cytotoxic Role over Colorectal Cancer Cells: Insights of Annexin A2 Regulation and Molecular Modeling.

Marcos Antonio Custódio Neto da Silva, Josiane Weber Tessmann, Kátia Regina Assunção Borges

|Dec 24, 2022
Mechanisms of radioresistance and the underlying signaling pathways in colorectal cancer cells.

Josiane W Tessmann, Murilo R Rocha, Jose A Morgado-Díaz

|Aug 09, 2022
Crosstalk between PI3K/Akt and Wnt/β-catenin pathways promote colorectal cancer progression regardless of mutational status.

Cassio Dejair Fleming-de-Moraes, Murilo Ramos Rocha, Josiane Weber Tessmann

|Oct 09, 2021
Epithelial-Mesenchymal Transition in colorectal cancer: Annexin A2 is caught in the crosshairs.

Murilo Ramos Rocha, Jose Andres Morgado-Diaz

Pageof 2